Find where to buy products from suppliers in the USA, including: distributors, industrial manufacturers in America, bulk supplies and wholesalers of raw ingredients & finished goods.
Search for products or services, then visit the American suppliers website for prices, SDS or more information. You can also view suppliers in Australia, NZ or the UK.
| Product | Description | |
|---|---|---|
| Cefuroxime axetil Impurity 1 | Cefuroxime axetil Impurity 1. Uses: For analytical and research use. Group: Impurity standards. Alternative Names: (6R,7R)-methyl 3-((carbamoyloxy)methyl)-7-((Z)-2-(furan-2-yl)-2-(methoxyimino)acetamido)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate. Molecular Formula: C17H18N4O8S. Mole Weight: 438.41. Catalog: APB04467. |  |
| Cefuroxime axetil Impurity 14 | Cefuroxime axetil Impurity 14. Uses: For analytical and research use. Group: Impurity standards. Alternative Names: (6R,7R)-7-amino-3-(((Z)-2-(furan-2-yl)-2-(methoxyimino)acetoxy)methyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid. Molecular Formula: C15H15N3O7S. Mole Weight: 381.36. Catalog: APB04461. | |
| Cefuroxime axetil Impurity 2 | Cefuroxime axetil Impurity 2. Uses: For analytical and research use. Group: Impurity standards. Alternative Names: (6R,7R)-7-amino-3-((carbamoyloxy)methyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid. Molecular Formula: C9H11N3O5S. Mole Weight: 273.27. Catalog: APB04464. | |
| Cefuroxime axetil Impurity A | Cefuroxime axetil Impurity A. Uses: For analytical and research use. Group: Impurity standards. Alternative Names: (6R,7R)-1-acetoxyethyl 3-((carbamoyloxy)methyl)-7-((Z)-2-(furan-2-yl)-2-(methoxyimino)acetamido)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-3-ene-2-carboxylate. CAS No. 123458-61-7. Molecular Formula: C20H22N4O10S. Mole Weight: 510.47. Catalog: APB123458617. | |
| Cefuroxime axetil Impurity B | Cefuroxime axetil Impurity B. Uses: For analytical and research use. Group: Impurity standards. Alternative Names: (6R,7R)-1-acetoxyethyl 3-((carbamoyloxy)methyl)-7-((E)-2-(furan-2-yl)-2-(methoxyimino)acetamido)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate. CAS No. 97232-96-7. Molecular Formula: C20H22N4O10S. Mole Weight: 510.47. Catalog: APB97232967. | |
| Cefuroxime axetil Impurity D | Cefuroxime axetil Impurity D. Uses: For analytical and research use. Group: Impurity standards. Alternative Names: (6R,7R)-3-((carbamoyloxy)methyl)-7-((Z)-2-(furan-2-yl)-2-(methoxyimino)acetamido)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid. CAS No. 55268-75-2. Molecular Formula: C16H16N4O8S. Mole Weight: 424.39. Catalog: APB55268752. | |
| Cefuroxime axetil Impurity E | Cefuroxime axetil Impurity E. Uses: For analytical and research use. Group: Impurity standards. Alternative Names: (Z)-N-((5aR,6R)-1,7-dioxo-1,3,4,5a,6,7-hexahydroazeto[2,1-b]furo[3,4-d][1,3]thiazin-6-yl)-2-(furan-2-yl)-2-(methoxyimino)acetamide. Molecular Formula: C15H13N3O6S. Mole Weight: 363.35. Catalog: APB04468. | |
| Cefuroxime Axetil Impurity E | (αZ)-α-(Methoxyimino)-N-[(5aR,6R)-1,4,5a,6-tetrahydro-1,7-dioxo-3H,7H-azeto[2,1-b]furo[3,4-d][1,3]thiazin-6-yl]-2-furanacetamide is an impurity of Cefuroxime Axetil, the 1-(acetyloxy) ethyl ester of Cefuroxime , an injectable second generation cephalosporin with an excellent antibacterial activity. Synonyms: (αZ)-α-(Methoxyimino)-N-[(5aR,6R)-1,4,5a,6-tetrahydro-1,7-dioxo-3H,7H-azeto[2,1-b]furo[3,4-d][1,3]thiazin-6-yl]-2-furanacetamide. Grades: > 95%. CAS No. 947723-87-7. Molecular formula: C15H13N3O6S. Mole weight: 363.35. |  |
| Cefuroxime axetil Dimer | Cefuroxime axetil Dimer. Uses: For analytical and research use. Group: Impurity standards. Alternative Names: 2-((2R)-4-((1-acetoxyethoxy)carbonyl)-5-((carbamoyloxy)methyl)-3-((6R,7R)-3-((carbamoyloxy)methyl)-7-((Z)-2-(furan-2-yl)-2-(methoxyimino)acetamido)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carbonyl)-3,6-dihydro-2H-1,3-thiazin-2-yl)-2-((Z)-2-(furan-2-yl. Molecular Formula: C36H38N8O18S2. Mole Weight: 934.86. Catalog: APB04463. | |
Our database is helping our users find suppliers everyday.
